Home The Word Brain Fast Track My Amedeo FAQ About Flying Publisher   

Fast Track

Ear2MemoryFree App | Free PDF | Web
Learning languages on your smartphone
By BSK

Free Abstracts

  Breast Cancer

  Free Subscription


Articles published in Oncogene

Retrieve available abstracts of 49 articles:
HTML format
Text format



Single Articles


    July 2017
  1. FETTIG LM, McGinn O, Finlay-Schultz J, LaBarbera DV, et al
    Cross talk between progesterone receptors and retinoic acid receptors in regulation of cytokeratin 5-positive breast cancer cells.
    Oncogene. 2017 Jul 10. doi: 10.1038/onc.2017.
    PubMed     Text format     Abstract available


    June 2017
  2. HERNANDEZ-PEREZ S, Cabrera E, Salido E, Lim M, et al
    DUB3 and USP7 de-ubiquitinating enzymes control replication inhibitor Geminin: molecular characterization and associations with breast cancer.
    Oncogene. 2017 Jun 26. doi: 10.1038/onc.2017.
    PubMed     Text format     Abstract available


  3. TANG X, Ding CK, Wu J, Sjol J, et al
    Cystine addiction of triple-negative breast cancer associated with EMT augmented death signaling.
    Oncogene. 2017 Jun 12. doi: 10.1038/onc.2017.
    PubMed     Text format     Abstract available


  4. SENGUPTA S, Nagalingam A, Muniraj N, Bonner MY, et al
    Activation of tumor suppressor LKB1 by honokiol abrogates cancer stem-like phenotype in breast cancer via inhibition of oncogenic Stat3.
    Oncogene. 2017 Jun 5. doi: 10.1038/onc.2017.
    PubMed     Text format     Abstract available


  5. SHAHI P, Wang CY, Chou J, Hagerling C, et al
    GATA3 targets semaphorin 3B in mammary epithelial cells to suppress breast cancer progression and metastasis.
    Oncogene. 2017 Jun 5. doi: 10.1038/onc.2017.
    PubMed     Text format     Abstract available


    April 2017
  6. JALAGUIER S, Teyssier C, Nait Achour T, Lucas A, et al
    Complex regulation of LCoR signaling in breast cancer cells.
    Oncogene. 2017 Apr 17. doi: 10.1038/onc.2017.
    PubMed     Text format     Abstract available


  7. CHEN Y, Zeng C, Zhan Y, Wang H, et al
    Aberrant low expression of p85alpha in stromal fibroblasts promotes breast cancer cell metastasis through exosome-mediated paracrine Wnt10b.
    Oncogene. 2017 Apr 10. doi: 10.1038/onc.2017.
    PubMed     Text format     Abstract available


  8. COHEN N, Shani O, Raz Y, Sharon Y, et al
    Fibroblasts drive an immunosuppressive and growth-promoting microenvironment in breast cancer via secretion of Chitinase 3-like 1.
    Oncogene. 2017 Apr 3. doi: 10.1038/onc.2017.
    PubMed     Text format     Abstract available


    March 2017
  9. THEWES V, Simon R, Hlevnjak M, Schlotter M, et al
    The branched-chain amino acid transaminase 1 sustains growth of antiestrogen-resistant and ERalpha-negative breast cancer.
    Oncogene. 2017 Mar 20. doi: 10.1038/onc.2017.
    PubMed     Text format     Abstract available


  10. FOO TK, Tischkowitz M, Simhadri S, Boshari T, et al
    Compromised BRCA1-PALB2 interaction is associated with breast cancer risk.
    Oncogene. 2017 Mar 20. doi: 10.1038/onc.2017.
    PubMed     Text format     Abstract available


  11. HERNANDEZ-PEREZ S, Cabrera E, Salido E, Lim M, et al
    DUB3 and USP7 de-ubiquitinating enzymes control replication inhibitor Geminin: molecular characterization and associations with breast cancer.
    Oncogene. 2017 Mar 13. doi: 10.1038/onc.2017.
    PubMed     Text format     Abstract available


  12. YU L, Di Y, Xin L, Ren Y, et al
    SND1 acts as a novel gene transcription activator recognizing the conserved Motif domains of Smad promoters, inducing TGFbeta1 response and breast cancer metastasis.
    Oncogene. 2017 Mar 6. doi: 10.1038/onc.2017.
    PubMed     Text format     Abstract available


    February 2017
  13. WU MJ, Kim MR, Chen YS, Yang JY, et al
    Retinoic acid directs breast cancer cell state changes through regulation of TET2-PKCzeta pathway.
    Oncogene. 2017 Feb 20. doi: 10.1038/onc.2016.
    PubMed     Text format     Abstract available


  14. LIN C, Liao W, Jian Y, Peng Y, et al
    CGI-99 promotes breast cancer metastasis via autocrine interleukin-6 signaling.
    Oncogene. 2017 Feb 6. doi: 10.1038/onc.2016.
    PubMed     Text format     Abstract available


    January 2017
  15. JHAN JR, Andrechek ER
    Effective personalized therapy for breast cancer based on predictions of cell signaling pathway activation from gene expression analysis.
    Oncogene. 2017 Jan 30. doi: 10.1038/onc.2016.
    PubMed     Text format     Abstract available


  16. HE Y, Northey JJ, Pelletier A, Kos Z, et al
    The Cdc42/Rac1 regulator CdGAP is a novel E-cadherin transcriptional co-repressor with Zeb2 in breast cancer.
    Oncogene. 2017 Jan 30. doi: 10.1038/onc.2016.
    PubMed     Text format     Abstract available


  17. YANG N, Wang C, Wang Z, Zona S, et al
    FOXM1 recruits nuclear Aurora kinase A to participate in a positive feedback loop essential for the self-renewal of breast cancer stem cells.
    Oncogene. 2017 Jan 23. doi: 10.1038/onc.2016.
    PubMed     Text format     Abstract available


  18. CRISTOBAL I, Zazo S, Torrejon B, Pedregal M, et al
    CIP2A confirms its prognostic value in triple-negative breast cancer.
    Oncogene. 2017 Jan 9. doi: 10.1038/onc.2016.
    PubMed     Text format    


  19. ZHOU H, Liu Y, Zhu R, Ding F, et al
    FBXO32 suppresses breast cancer tumorigenesis through targeting KLF4 to proteasomal degradation.
    Oncogene. 2017 Jan 9. doi: 10.1038/onc.2016.
    PubMed     Text format     Abstract available


    November 2016
  20. FENG J, Li L, Zhang N, Liu J, et al
    Androgen and AR contribute to breast cancer development and metastasis: an insight of mechanisms.
    Oncogene. 2016 Nov 28. doi: 10.1038/onc.2016.
    PubMed     Text format     Abstract available


  21. YU L, Liang Y, Cao X, Wang X, et al
    Identification of MYST3 as a novel epigenetic activator of ERalpha frequently amplified in breast cancer.
    Oncogene. 2016 Nov 28. doi: 10.1038/onc.2016.
    PubMed     Text format     Abstract available


  22. HIKEN JF, McDonald JI, Decker KF, Sanchez C, et al
    Epigenetic activation of the prostaglandin receptor EP4 promotes resistance to endocrine therapy for breast cancer.
    Oncogene. 2016 Nov 21. doi: 10.1038/onc.2016.
    PubMed     Text format     Abstract available


  23. TANG X, Ding CK, Wu J, Sjol J, et al
    Cystine addiction of triple-negative breast cancer associated with EMT augmented death signaling.
    Oncogene. 2016 Nov 21. doi: 10.1038/onc.2016.
    PubMed     Text format     Abstract available


    October 2016
  24. BLOMME A, Costanza B, de Tullio P, Thiry M, et al
    Myoferlin regulates cellular lipid metabolism and promotes metastases in triple-negative breast cancer.
    Oncogene. 2016 Oct 24. doi: 10.1038/onc.2016.
    PubMed     Text format     Abstract available


  25. YANG C, Li Z, Bhatt T, Dickler M, et al
    Acquired CDK6 amplification promotes breast cancer resistance to CDK4/6 inhibitors and loss of ER signaling and dependence.
    Oncogene. 2016 Oct 17. doi: 10.1038/onc.2016.
    PubMed     Text format     Abstract available


  26. HARROD A, Fulton J, Nguyen VT, Periyasamy M, et al
    Genomic modelling of the ESR1 Y537S mutation for evaluating function and new therapeutic approaches for metastatic breast cancer.
    Oncogene. 2016 Oct 17. doi: 10.1038/onc.2016.
    PubMed     Text format     Abstract available


  27. MIMOTO R, Imawari Y, Hirooka S, Takeyama H, et al
    Impairment of DYRK2 augments stem-like traits by promoting KLF4 expression in breast cancer.
    Oncogene. 2016 Oct 10. doi: 10.1038/onc.2016.
    PubMed     Text format     Abstract available


  28. LONE MU, Baghel KS, Kanchan RK, Shrivastava R, et al
    Physical interaction of estrogen receptor with MnSOD: implication in mitochondrial O2.- upregulation and mTORC2 potentiation in estrogen-responsive breast cancer cells.
    Oncogene. 2016 Oct 10. doi: 10.1038/onc.2016.
    PubMed     Text format     Abstract available


  29. LIU H, Qiu H, Song Y, Liu Y, et al
    Cip2a promotes cell cycle progression in triple-negative breast cancer cells by regulating the expression and nuclear export of p27Kip1.
    Oncogene. 2016 Oct 3. doi: 10.1038/onc.2016.
    PubMed     Text format     Abstract available


    September 2016
  30. LEFORT S, Thuleau A, Kieffer Y, Sirven P, et al
    CXCR4 inhibitors could benefit to HER2 but not to triple-negative breast cancer patients.
    Oncogene. 2016 Sep 26. doi: 10.1038/onc.2016.
    PubMed     Text format     Abstract available


  31. YU PF, Huang Y, Xu CL, Lin LY, et al
    Downregulation of CXCL12 in mesenchymal stromal cells by TGFbeta promotes breast cancer metastasis.
    Oncogene. 2016 Sep 26. doi: 10.1038/onc.2016.
    PubMed     Text format     Abstract available


  32. KWAK T, Drews-Elger K, Ergonul A, Miller PC, et al
    Targeting of RAGE-ligand signaling impairs breast cancer cell invasion and metastasis.
    Oncogene. 2016 Sep 26. doi: 10.1038/onc.2016.
    PubMed     Text format     Abstract available


  33. CHANG SS, Yamaguchi H, Xia W, Lim SO, et al
    Aurora A kinase activates YAP signaling in triple-negative breast cancer.
    Oncogene. 2016 Sep 5. doi: 10.1038/onc.2016.
    PubMed     Text format     Abstract available


  34. KANG MH, Jeong KJ, Kim WY, Lee HJ, et al
    Musashi RNA-binding protein 2 regulates estrogen receptor 1 function in breast cancer.
    Oncogene. 2016 Sep 5. doi: 10.1038/onc.2016.
    PubMed     Text format     Abstract available


    August 2016
  35. TOMINAGA K, Shimamura T, Kimura N, Murayama T, et al
    Addiction to the IGF2-ID1-IGF2 circuit for maintenance of the breast cancer stem-like cells.
    Oncogene. 2016 Aug 22. doi: 10.1038/onc.2016.
    PubMed     Text format     Abstract available


  36. XU Y, Qin L, Sun T, Wu H, et al
    Twist1 promotes breast cancer invasion and metastasis by silencing Foxa1 expression.
    Oncogene. 2016 Aug 15. doi: 10.1038/onc.2016.
    PubMed     Text format     Abstract available


    July 2016
  37. YU PF, Huang Y, Han YY, Lin LY, et al
    TNFalpha-activated mesenchymal stromal cells promote breast cancer metastasis by recruiting CXCR2+ neutrophils.
    Oncogene. 2016 Jul 4. doi: 10.1038/onc.2016.
    PubMed     Text format     Abstract available


    June 2016
  38. SAHA SK, Choi HY, Kim BW, Dayem AA, et al
    KRT19 directly interacts with beta-catenin/RAC1 complex to regulate NUMB-dependent NOTCH signaling pathway and breast cancer properties.
    Oncogene. 2016 Jun 27. doi: 10.1038/onc.2016.
    PubMed     Text format     Abstract available


  39. XU LZ, Li SS, Zhou W, Kang ZJ, et al
    p62/SQSTM1 enhances breast cancer stem-like properties by stabilizing MYC mRNA.
    Oncogene. 2016 Jun 27. doi: 10.1038/onc.2016.
    PubMed     Text format     Abstract available


  40. FERRER CM, Lu TY, Bacigalupa ZA, Katsetos CD, et al
    O-GlcNAcylation regulates breast cancer metastasis via SIRT1 modulation of FOXM1 pathway.
    Oncogene. 2016 Jun 27. doi: 10.1038/onc.2016.
    PubMed     Text format     Abstract available


  41. WERDEN SJ, Sphyris N, Sarkar TR, Paranjape AN, et al
    Phosphorylation of serine 367 of FOXC2 by p38 regulates ZEB1 and breast cancer metastasis, without impacting primary tumor growth.
    Oncogene. 2016 Jun 13. doi: 10.1038/onc.2016.
    PubMed     Text format     Abstract available


  42. DA MOTTA LL, Ledaki I, Purshouse K, Haider S, et al
    The BET inhibitor JQ1 selectively impairs tumour response to hypoxia and downregulates CA9 and angiogenesis in triple negative breast cancer.
    Oncogene. 2016 Jun 13. doi: 10.1038/onc.2016.
    PubMed     Text format     Abstract available


  43. RAMADOSS S, Guo G, Wang CY
    Lysine demethylase KDM3A regulates breast cancer cell invasion and apoptosis by targeting histone and the non-histone protein p53.
    Oncogene. 2016 Jun 6. doi: 10.1038/onc.2016.
    PubMed     Text format     Abstract available


    May 2016
  44. CAO C, Vasilatos SN, Bhargava R, Fine JL, et al
    Functional interaction of histone deacetylase 5 (HDAC5) and lysine-specific demethylase 1 (LSD1) promotes breast cancer progression.
    Oncogene. 2016 May 23. doi: 10.1038/onc.2016.
    PubMed     Text format     Abstract available


  45. FARMAKI E, Chatzistamou I, Kaza V, Kiaris H, et al
    A CCL8 gradient drives breast cancer cell dissemination.
    Oncogene. 2016 May 16. doi: 10.1038/onc.2016.
    PubMed     Text format     Abstract available


  46. HEIN AL, Post CM, Sheinin YM, Lakshmanan I, et al
    RAC1 GTPase promotes the survival of breast cancer cells in response to hyper-fractionated radiation treatment.
    Oncogene. 2016 May 16. doi: 10.1038/onc.2016.
    PubMed     Text format     Abstract available


  47. MENDOZA-VILLANUEVA D, Balamurugan K, Ali HR, Kim SR, et al
    The C/EBPdelta protein is stabilized by estrogen receptor alpha activity, inhibits SNAI2 expression and associates with good prognosis in breast cancer.
    Oncogene. 2016 May 16. doi: 10.1038/onc.2016.
    PubMed     Text format     Abstract available


  48. TURPIN J, Ling C, Crosby EJ, Hartman ZC, et al
    The ErbB2DeltaEx16 splice variant is a major oncogenic driver in breast cancer that promotes a pro-metastatic tumor microenvironment.
    Oncogene. 2016 May 9. doi: 10.1038/onc.2016.
    PubMed     Text format     Abstract available


  49. TEO WW, Merino VF, Cho S, Korangath P, et al
    HOXA5 determines cell fate transition and impedes tumor initiation and progression in breast cancer through regulation of E-cadherin and CD24.
    Oncogene. 2016 May 9. doi: 10.1038/onc.2016.
    PubMed     Text format     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Breast Cancer is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: